Literature DB >> 34921771

RNA epitranscriptomics: A promising new avenue for cancer therapy.

Chunlong Yang1, Hui Han1, Shuibin Lin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34921771      PMCID： PMC8753512          DOI： 10.1016/j.ymthe.2021.12.008

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  8 in total

1.  The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells.

Authors:  Shuibin Lin; Junho Choe; Peng Du; Robinson Triboulet; Richard I Gregory
Journal:  Mol Cell       Date:  2016-04-21       Impact factor: 17.970

Review 2.  The current landscape of nucleic acid therapeutics.

Authors:  Jayesh A Kulkarni; Dominik Witzigmann; Sarah B Thomson; Sam Chen; Blair R Leavitt; Pieter R Cullis; Roy van der Meel
Journal:  Nat Nanotechnol       Date:  2021-05-31       Impact factor: 39.213

3.  Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia.

Authors:  Eliza Yankova; Wesley Blackaby; Mark Albertella; Justyna Rak; Etienne De Braekeleer; Georgia Tsagkogeorga; Ewa S Pilka; Demetrios Aspris; Dan Leggate; Alan G Hendrick; Natalie A Webster; Byron Andrews; Richard Fosbeary; Patrick Guest; Nerea Irigoyen; Maria Eleftheriou; Malgorzata Gozdecka; Joao M L Dias; Andrew J Bannister; Binje Vick; Irmela Jeremias; George S Vassiliou; Oliver Rausch; Konstantinos Tzelepis; Tony Kouzarides
Journal:  Nature       Date:  2021-04-26       Impact factor: 69.504

Review 4.  The chemical diversity of RNA modifications.

Authors:  R Jordan Ontiveros; Julian Stoute; Kathy Fange Liu
Journal:  Biochem J       Date:  2019-04-26       Impact factor: 3.766

5.  Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia.

Authors:  Yue Huang; Rui Su; Yue Sheng; Lei Dong; Ze Dong; Hongjiao Xu; Tengfeng Ni; Zijie Scott Zhang; Tao Zhang; Chenying Li; Li Han; Zhenyun Zhu; Fulin Lian; Jiangbo Wei; Qiangqiang Deng; Yungui Wang; Mark Wunderlich; Zhiwei Gao; Guoyu Pan; Dafang Zhong; Hu Zhou; Naixia Zhang; Jianhua Gan; Hualiang Jiang; James C Mulloy; Zhijian Qian; Jianjun Chen; Cai-Guang Yang
Journal:  Cancer Cell       Date:  2019-04-15       Impact factor: 38.585

6.  MODOMICS: a database of RNA modification pathways. 2017 update.

Authors:  Pietro Boccaletto; Magdalena A Machnicka; Elzbieta Purta; Pawel Piatkowski; Blazej Baginski; Tomasz K Wirecki; Valérie de Crécy-Lagard; Robert Ross; Patrick A Limbach; Annika Kotter; Mark Helm; Janusz M Bujnicki
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

7.  R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling.

Authors:  Rui Su; Lei Dong; Chenying Li; Sigrid Nachtergaele; Mark Wunderlich; Ying Qing; Xiaolan Deng; Yungui Wang; Xiaocheng Weng; Chao Hu; Mengxia Yu; Jennifer Skibbe; Qing Dai; Dongling Zou; Tong Wu; Kangkang Yu; Hengyou Weng; Huilin Huang; Kyle Ferchen; Xi Qin; Bin Zhang; Jun Qi; Atsuo T Sasaki; David R Plas; James E Bradner; Minjie Wei; Guido Marcucci; Xi Jiang; James C Mulloy; Jie Jin; Chuan He; Jianjun Chen
Journal:  Cell       Date:  2017-12-14       Impact factor: 66.850
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.